Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center